Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography-photo-diode array detection.
A chromatographic method, which can quantitate mitomycin C (MMC) along with two antiglaucoma drugs, is described. The separation of MMC, alphagan and timolol was performed on a reversed-phase C18 column with water-methanol-trifluoroacetic acid (65:35:0.01, v/v) as the mobile phase. By monitoring at 360, 248 and 296 nm, the lower limits of detection for MMC, alphagan and timolol are, respectively, 1.0, 2.0 and 5.0 ng (injection amount) at three-time S/N ratio. The dynamic ranges of quantitation for the three drugs are, respectively, 1.0 ng-10.0 microg, 2.0 ng-10.0 microg and 5.0 ng-10.0 microg with linearity being larger than 0.9960. This method was applied to the determination of MMC levels in Tenon's and trabeculum tissues of 10 glaucoma patients. MMC levels in these tissues, which were obtained from glaucoma filtering surgery, were determined following a multiple extraction with methanol. The recovery of MMC for a two-batch extraction was better than 91.2%. The reproducibility of measurement for the MMC levels in these tissues is 2.5-6.0% RSD for triplicate injections. The intra-day variation of retention times for the MMC peaks was less than 1.6% RSD (n=3). The inter-day variation of retention times for the MMC peaks was less than 4.8% RSD (n=3). MMC was detectable in three trabeculum tissues out of 10 cases (ranging from 0.8 to 25.5 ng/mg specimen), while MMC was detected in nine Tenon's tissues out of 10 cases (ranging from 0.3 to 21.1 ng/mg specimen). The results obtained show that the method is sensitive and selective for the quantitation of MMC.
Xiong
X
X
Singapore Eye Research Institute, Singapore. seri_xx@hotmail.com
Lim
B A
BA
Lat-Luna
M
M
Chew
P
P
Tan
D
D
D000959:Antihypertensive Agents / Q000737:chemistry / Q000627:therapeutic use; D000068438:Brimonidine Tartrate; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D005901:Glaucoma / Q000601:surgery; D006801:Humans; D016685:Mitomycin / Q000032:analysis* / Q000737:chemistry / Q000627:therapeutic use; D015394:Molecular Structure; D011292:Premedication; D011810:Quinoxalines / Q000737:chemistry / Q000627:therapeutic use; D012590:Sclera / Q000737:chemistry* / Q000378:metabolism; D013999:Timolol / Q000737:chemistry / Q000627:therapeutic use; D014130:Trabeculectomy
D000959:Antihypertensive Agents; D011810:Quinoxalines; D000068438:Brimonidine Tartrate; D016685:Mitomycin; D013999:Timolol